Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-112500
Filing Date
2025-09-02
Accepted
2025-09-02 16:30:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8600
  Complete submission text file 0000950170-25-112500.txt   10490
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-87951 | Film No.: 251285898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018
Business Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018 41 21 614 3500
HealthCap VII, L.P. (Filed by) CIK: 0001645161 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A